Form 8-K - Current report:
SEC Accession No. 0001731122-21-001568
Filing Date
2021-09-27
Accepted
2021-09-27 08:10:32
Documents
13
Period of Report
2021-09-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e3115_8k.htm   iXBRL 8-K 28452
2 EXHIBIT 99.1 e3115_ex99-1.htm EX-99.1 10172
  Complete submission text file 0001731122-21-001568.txt   215751

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE avxl-20210927.xsd EX-101.SCH 3019
4 XBRL LABEL FILE avxl-20210927_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE avxl-20210927_pre.xml EX-101.PRE 22355
6 EXTRACTED XBRL INSTANCE DOCUMENT e3115_8k_htm.xml XML 3707
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37606 | Film No.: 211279025
SIC: 8731 Services-Commercial Physical & Biological Research